Neil Brown, MD
Otolaryngology · Rochester, MNNPI 1457332934
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Acclarent, Inc at 48.2% of the total. Reporting peaked in 2024 at $451 and has fallen 55.4% since, to $201 in 2025.
Across 22 payments — averaging $68.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$724
- Integra Lifesciences Corporation$348
- Intersect ENT, Inc.$186
- Cochlear Americas$128
- Stryker$43
- BD$37
- plus $36 from 2 others
What the payments were for
- Food & beverage$1,503100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 10 | $724 |
| Integra Lifesciences Corporation | 3 | $348 |
| Intersect ENT, Inc. | 3 | $186 |
| Cochlear Americas | 1 | $128 |
| Stryker | 2 | $43 |
| BD | 1 | $37 |
| Preceptis Medical, Inc. | 1 | $22 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,503 in reported general payments places this provider in the 70th percentile of 181 otolaryngology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 25 | $3,163 |
| Azelastine Hcl | 133 | $3,066 |
| Ipratropium Bromide | 49 | $1,616 |
| Fluocinolone Acetonide Oil | 27 | $1,160 |
| Pantoprazole Sodium | 24 | $400 |
| Mupirocin | 45 | $340 |
| Ofloxacin | 15 | $274 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $154 |
| Prednisone | 23 | $78 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Rochester
- Matthew CarlsonRochester$80K
- Rijul KshirsagarRochester$18K
- Brian NeffRochester$16K
- Carlos Pinheiro NetoRochester$11K
- Dale EkbomRochester$9K
- Terenece ZimmermannRochester$7K
- James DornhofferRochester$5K
- Colin DriscollRochester$5K
- Joshua WiedermannRochester$4K
- Eleni RettigRochester$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.